Hana Cernecka
Groningen, GR 9713AV, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effects of the P2RX4 antagonist BR11595 in a guinea pig model of chronic asthma.
Journal: British journal of pharmacology
Published: December 21, 2024
Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists.
Journal: The Journal of clinical investigation
Published: December 01, 2021
Cyclin-Dependent Kinase 18 Controls Trafficking of Aquaporin-2 and Its Abundance through Ubiquitin Ligase STUB1, Which Functions as an AKAP.
Journal: Cells
Published: February 03, 2020
Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat.
Journal: European journal of pharmacology
Published: April 18, 2016
β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 12, 2015
Rat β₃-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 09, 2014
The odd sibling: features of β3-adrenoceptor pharmacology.
Journal: Molecular pharmacology
Published: June 04, 2014
The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.
Journal: Current opinion in pharmacology
Published: December 16, 2013
Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat.
Journal: European journal of pharmacology
Published: August 08, 2013
Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy.
Journal: European journal of pharmacology
Published: December 07, 2012
Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction.
Journal: The Journal of pharmacy and pharmacology
Published: April 05, 2012
Last Updated: 09/26/2026